Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Cholangiocarcinoma × Electroporation × Clear all

Phase

Status

Withdrawn 1 Unknown 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 2 Prostatic Neoplasms 1 Pancreatic Adenocarcinoma Resectable 1 Melanoma 1 Cholangiocarcinoma 1 Bile Duct Neoplasms 1

Interventions

Gemcitabine 4 Cisplatin 3 infigratinib 2 Fluorouracil 2 niraparib 1 lenvatinib 1 galactomannan 1 fludarabine 1 famitinib 1 dostarlimab 1 atezolizumab 1 aldesleukin 1 Taxes 1 Sildenafil Citrate 1 Sevoflurane 1 Platinum 1 Photochemotherapy 1 Oxaliplatin 1 Observation 1 NVP-BKM120 1 Interviews as Topic 1 IMC-001 1 Electroporation 1 Desflurane 1 Cyclophosphamide 1 Capecitabine 1 Bevacizumab 1 Albumin-Bound Paclitaxel 1 130-nm albumin-bound paclitaxel 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04717687 2022-07-13

HOPE

Poitiers University Hospital

Phase NA Withdrawn

Gastrointestinal

Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡